Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03861169 · ClinicalTrials.gov registry record · NA
Study of OMNI System in OAG (GEMINI)
A NA study, sponsored by Sight Sciences.
- Completed
- Registry status
- NA
- Development phase
- 209
- Enrollment target
NCT03861169 is a NA study that has completed, run by Sight Sciences. The registered enrollment target is 209 participants.
The verdict
NCT03861169, a NA study, has completed, sponsored by Sight Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 209 participants
- Enrollment target
Study Summary
This study will prospectively assess the clinical effect of ab-interno transluminal viscoelastic delivery and trabeculotomy performed using the OMNI Surgical System in combination with Cataract Extraction on intraocular pressure (IOP) and the use of IOP-lowering medications in patients with mild-moderate open angle glaucoma (OAG).
Interventions
- DEVICE Transluminal viscoelastic delivery and trabeculotomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 209 participants |
| Start Date | 2019-03-11 |
| Est. Completion | 2021-05-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03861169
The ClinicalTrials.gov registry entry for NCT03861169 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 209 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sight Sciences, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transluminal viscoelastic delivery and trabeculotomy is the first listed.
NCT03861169 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03861169 about?
NCT03861169 is a clinical study titled "Study of OMNI System in OAG (GEMINI)". This study will prospectively assess the clinical effect of ab-interno transluminal viscoelastic delivery and trabeculotomy performed using the OMNI Surgical System in combination with Cataract Extraction on intraocular pressure (IOP) and the use of IOP-lowering medications in patients with mild-mod...
What is the current status of trial NCT03861169?
This trial is currently completed. It is a NA study. The enrollment target is 209 participants. The study started on 2019-03-11. Estimated completion is 2021-05-04.
What interventions are being tested in trial NCT03861169?
The interventions under investigation include: Transluminal viscoelastic delivery and trabeculotomy (DEVICE).
Who is sponsoring clinical trial NCT03861169?
This trial is sponsored by Sight Sciences, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.